Evidence map›Paper›PMID 31964743›Full record

ArticleInfection and immunity2020

Polymorphisms within the

C B Lupiañez, M Martínez-Bueno, J M Sánchez-Maldonado, J Badiola, C Cunha, J Springer, M Lackner, J Segura-Catena, L M Canet, L Alcazar-Fuoli and 25 more

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Polymorphisms within theJournal of fungi (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 13 institutions in 6 countries.

C B LupiañezGenomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
M Martínez-BuenoGenomic Medicine Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
J M Sánchez-MaldonadoGenomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
J BadiolaHematology Department, Virgen de las Nieves University Hospital, Granada, Spain.
C CunhaLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
J SpringerUniversitätsklinikum Würzburg, Medizinische Klinik II, Würzburg, Germany.
M LacknerDivision of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
J Segura-CatenaGenomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
L M CanetGenomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
L Alcazar-FuoliMycology Reference Laboratory, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Madrid, Spain.
M A López-NevotImmunology Department, Virgen de las Nieves University Hospital, Granada, Spain.
L FianchiIstituto di Ematologia, Università Cattolica del S. Cuore, Rome, Italy.
J M AguadoUnit of Infectious Diseases, Hospital Universitario "12 de Octubre," Instituto de Investigación Hospital "12 de Octubre" (i+12), Madrid, Spain.
L PaganoIstituto di Ematologia, Università Cattolica del S. Cuore, Rome, Italy.
E López-FernándezGenomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
M Alarcón-RiquelmeGenomic Medicine Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
L PotenzaDepartment of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, Modena, Italy.
S M GonçalvesLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
M LuppiDepartment of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, Modena, Italy.
L MoratallaGenomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
C SolanoHematology Department, Hospital Clinico Universitario-INCLIVA, University of Valencia, Spain.
A SampedroInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.
P González-SierraGenomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
M Cuenca-EstrellaMycology Reference Laboratory, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Madrid, Spain.
K LagrouDepartment of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
J A MaertensDepartment of Hematology, University Hospitals Leuven, Leuven, Belgium.
C Lass-FlörlDivision of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
H EinseleUniversitätsklinikum Würzburg, Medizinische Klinik II, Würzburg, Germany.
L VazquezHematology Department, University Hospital of Salamanca, Salamanca, Spain.
PCRAGA Study Group
J LoefflerUniversitätsklinikum Würzburg, Medizinische Klinik II, Würzburg, Germany.
R Ríos-TamayoGenomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
A CarvalhoLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
M Jurado *Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
J Sainz *Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain juan.sainz@genyo.es.
Universidad de Granada · ESUniversitätsklinikum Würzburg · DEInnsbruck Medical University · ATInstituto de Salud Carlos III · ESKU Leuven · BEPfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research · ESUniversità Cattolica del Sacro Cuore · ITUniversity of Minho · PTUniversity of Modena and Reggio Emilia · ITHospital Universitario Virgen de las Nieves · ESResearch Institute Hospital 12 de Octubre · ESUniversidad de Salamanca · ESUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive aspergillosis (IA) is a life-threatening infection that affects an increasing number of patients undergoing chemotherapy or allo-transplantation, and recent studies have shown that genetic factors contribute to disease susceptibility. In this two-stage, population-based, case-control study, we evaluated whether 7 potentially functional single nucleotide polymorphisms (SNPs) within the

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideAryl Hydrocarbon Receptor Nuclear TranslocatorAspergillusBasic Helix-Loop-Helix ProteinsCase-Control StudiesCX3C Chemokine Receptor 1GenotypeHematologic DiseasesHumansInvasive Pulmonary AspergillosisRisk AssessmentARNT2 protein, humanAryl Hydrocarbon Receptor Nuclear TranslocatorBasic Helix-Loop-Helix ProteinsCX3C Chemokine Receptor 1CX3CR1 protein, humanARNT2CX3CR1genetic susceptibilityhost immunityinvasive aspergillosis

Identifiers

PMID31964743
PMCPMC7093133
OpenAlexW3000131467

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.